Smoke Free

Dieffenbachia Seguine, Daphne Odora Bark, Graphites, Valerian


Schwabe Mexico, S.a. De C.v.
Human Otc Drug
NDC 68466-0598
Smoke Free also known as Dieffenbachia Seguine, Daphne Odora Bark, Graphites, Valerian is a human otc drug labeled by 'Schwabe Mexico, S.a. De C.v.'. National Drug Code (NDC) number for Smoke Free is 68466-0598. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Smoke Free drug includes Daphne Odora Bark - 12 [hp_X]/1 Dieffenbachia Seguine - 6 [hp_X]/1 Graphite - 12 [hp_X]/1 Valerian - 6 [hp_X]/1 . The currest status of Smoke Free drug is Active.

Drug Information:

Drug NDC: 68466-0598
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Smoke Free
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Dieffenbachia Seguine, Daphne Odora Bark, Graphites, Valerian
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Schwabe Mexico, S.a. De C.v.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Tablet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:DAPHNE ODORA BARK - 12 [hp_X]/1
DIEFFENBACHIA SEGUINE - 6 [hp_X]/1
GRAPHITE - 12 [hp_X]/1
VALERIAN - 6 [hp_X]/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:SUBLINGUAL
SUBLINGUAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Jun, 2017
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 30 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 05 May, 2026
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Schwabe Mexico, S.A. de C.V.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0308078105987
UPC stands for Universal Product Code.
UNII:JSJ34YQJ5D
01800C6E6B
4QQN74LH4O
JWF5YAW3QW
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
68466-0598-11 BOTTLE, GLASS in 1 BOX (68466-0598-1) / 100 TABLET in 1 BOTTLE, GLASS01 Jun, 201730 Dec, 2025No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose to reduce withdrawal symptoms, including cravings to smoke, withdrawal nerves, and increased appetite.

Product Elements:

Smoke free dieffenbachia seguine, daphne odora bark, graphites, valerian dieffenbachia seguine dieffenbachia seguine daphne odora bark daphne odora bark graphite graphite valerian valerian microcrystalline cellulose lactose monohydrate magnesium stearate b;t bt b;t

Indications and Usage:

Indications and usage to reduce withdrawal symptoms, including cravings to smoke, withdrawal nerves, and increased appetite.

Warnings:

Warning stop use and ask a doctor if condition does not improve in 4 weeks.

Dosage and Administration:

Dosage & administration: directions: sublingual medication. place tablet under tongue and let dissolve. tablets work best when taken at least 15 minutes before or after eating, brushing your teeth, or drinking anything except water. adults: stop smoking completely. weeks 1 through 3, 1 tablet every hour. weeks 4 through 6, 1 tablet every 2 hours, or as needed. weeks 7 through 9, 1 tablet 4 times a day, or as needed.

Overdosage:

Overdose in case of overdose, seek medical help or contact a poison control center immediately.

Package Label Principal Display Panel:

Smokefree_21810598_04.jpg


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.